Innova Remedies Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 30-06-2024
- Paid Up Capital ₹ 5.00 M
as on 30-06-2024
- Company Age 25 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.38 Cr
as on 30-06-2024
- Satisfied Charges ₹ 4.40 M
as on 30-06-2024
- Revenue 85.09%
(FY 2022)
- Profit 379.65%
(FY 2022)
- Ebitda 116.60%
(FY 2022)
- Net Worth 21.85%
(FY 2022)
- Total Assets 37.59%
(FY 2022)
About Innova Remedies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹1.38 Cr. The company has closed loans amounting to ₹4.40 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Khandelwal, Rakesh Khandelwal, Umang Khandelwal, and One other member serve as directors at the Company.
- CIN/LLPIN
U24200MH1999PTC120495
- Company No.
120495
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jun 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Innova Remedies?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Khandelwal  | Whole-Time Director | 24-Jun-1999 | Current |
| Amit Khandelwal | Whole-Time Director | 30-Dec-2004 | Current |
| Umang Khandelwal | Director | 03-Sep-2022 | Current |
| Sulabh Khandelwal | Whole-Time Director | 18-Jan-2010 | Current |
Financial Performance of Innova Remedies.
Innova Remedies Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 85.09% increase. The company also saw a substantial improvement in profitability, with a 379.65% increase in profit. The company's net worth Soared by an impressive increase of 21.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Innova Remedies?
In 2021, Innova Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Innova Pharmactive Private LimitedActive 14 years 6 monthsAmit Khandelwal, Rakesh Khandelwal and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 13 Dec 2016 | ₹1.38 Cr | Open |
State Bank Of India Creation Date: 29 Mar 2004 | ₹4.40 M | Satisfied |
How Many Employees Work at Innova Remedies?
Unlock and access historical data on people associated with Innova Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Innova Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innova Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
